Shareholders' Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 28, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shareholders' Equity | The following table summarizes changes to our common stock for the years ended June 28, 2026 and June 29, 2025:
During fiscal 2026, the Company repurchased 110,269 shares of common stock under its previously authorized share repurchase program at a total cost of $7.4 million. On May 28, 2026, the Board of Directors terminated the prior authorization and approved a new share repurchase program authorizing repurchases of up to $40.0 million of the Company's outstanding common stock. As of June 28, 2026, no shares had been repurchased under the new authorization. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||